Diagnostic Kits/Competitive advantages in Kits

From Commons Based Research
< Diagnostic Kits
Revision as of 12:54, 29 October 2009 by AClearwater (talk | contribs) (penumbra effect and The Myriad Story)
Jump to navigation Jump to search

Answer the questions:

  1. Define the competitive advantages in the field and the barriers of entry

penumbra effect

  • tests with genes in common lead to one lab having a functional monopoly over the group of diseases that require the common gene or mutation Cook-Deegan et. al., 2009.

The Myriad Story

  • Patent-Mediated Standards in Genetic Testing

Navigation

Main Page Diagnostic_Kits

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Competitive_advantages_in_Kits&oldid=4845"